Table 31.4—Antipsychotic Agents for the Treatment of Psychosis (Hallucinations and Delusions) in Dementia

Drug

Daily Dose

Adverse Effects

Comments

Formulations

AripiprazoleOL

5–15 mg

Mild sedation, mild hypotension

Warning about increased cerebrovascular events in dementia, possible hyperglycemia

Tablet, liquid concentrate

ClozapineOL

12.5–200 mg

Sedation, hypotension, anticholinergic effects, agranulocytosis

Weekly CBCs required, poorly tolerated by older adults, reserved for treatment of refractory cases, warning about hyperglycemia

Tablet, rapidly dissolving tablet

OlanzapineOL

2.5–10 mg

Sedation, falls, gait disturbance

Warning about hyperglycemia and cerebrovascular events in patients with dementia

Tablet, rapidly dissolving tablet, IM injection

QuetiapineOL

25–200 mg

Sedation, hypotension

Warning about hyperglycemia, ophthalmologic exam recommended every 6 months

Tablet

RisperidoneOL

0.5–2 mg

Sedation, hypotension, EPS with doses > 1 mg/day

Warning about cerebrovascular events in patients with dementia, hyperglycemia warning

Tablet, rapidly dissolving tablet, liquid concentrate, depot IM injection

ZiprasidoneOL

40–160 mg

Higher risk of QTc prolongation

Warning regarding increased QTc prolongation, possible hyperglycemia

Little published information on use in older adults

Capsule, IM injection

NOTE: CBCs = complete blood cell counts; EPS = extrapyramidal symptoms; IM = intramuscular.